|
1
|
Gewefel H and Salhia B: Breast cancer in
adolescent and young adult women. Clin Breast Cancer. 14:390–395.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clough KB, Kaufman GJ, Nos C, Buccimazza I
and Sarfati IM: Reply to comments on: Improving breast cancer
surgery: A classification and quadrant per quadrant atlas for
oncoplastic surgery. Ann Surg Oncol. 18:259–260. 2011. View Article : Google Scholar
|
|
3
|
Graham PJ, Brar MS, Foster T, McCall M,
Bouchard-Fortier A, Temple W and Quan ML: Neoadjuvant chemotherapy
for breast cancer, is practice changing? A population-based review
of current surgical trends. Ann Surg Oncol. 22:3376–3382. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dai D, Jin H and Wang X: Nomogram for
predicting survival in triple-negative breast cancer patients with
histology of infiltrating duct carcinoma: A population-based study.
Am J Cancer Res. 8:1576–1585. 2018.PubMed/NCBI
|
|
5
|
Lee SK, Yang JH, Woo SY, Lee JE and Nam
SJ: Nomogram for predicting invasion in patients with a
preoperative diagnosis of ductal carcinoma in situ of the breast.
Br J Surg. 100:1756–1763. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balachandran VP, Gonen M, Smith JJ and
Dematteo RP: Nomograms in oncology: More than meets the eye. Lancet
Oncol. 16:e173–e180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mortazavi A, Williams BA, McCue K,
Schaeffer L and Wold B: Mapping and quantifying mammalian
transcriptomes by RNA-Seq. Nat Methods. 5:621–628. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han Y, Xu GX, Lu H, Yu DH, Ren Y, Wang L,
Huang XH, Hou WJ, Wei ZH, Chen YP, et al: Dysregulation of miRNA-21
and their potential as biomarkers for the diagnosis of cervical
cancer. Int J Clin Exp Pathol. 8:7131–7139. 2015.PubMed/NCBI
|
|
9
|
Lee E, Collazolorduy A, Castillomartin M,
Gong Y, Wang L, Oh WK, Galsky MD, Cordon-Cardo C and Zhu J:
Identification of microR-106b as a prognostic biomarker of p53-like
bladder cancers by ActMiR. Oncogene. 37:5858–5872. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yue X, Lan F, Hu M, Pan Q, Wang Q and Wang
J: Downregulation of serum microRNA-205 as a potential diagnostic
and prognostic biomarker for human glioma. J Neurosurg.
124:122–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lelo A, Prip F, Harris BT, Solomon D,
Berry DL, Chaldekas K, Kumar A, Simko J, Jensen JB, Bhattacharyya
P, et al: STAG2 is a biomarker for prediction of recurrence and
progression in papillary non-muscle-invasive bladder cancer. Clin
Cancer Res. 24:4145–4153. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng A, Tu Z and Yin B: The effect of
HMGB1 on the clinicopathological and prognostic features of
non-small cell lung cancer. Oncotarget. 7:20507–20519. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng F, Shi X, Meng Y, Dong B, Xu G, Hou
T, Shi Y and Liu T: Long non-coding RNA HOTTIP is upregulated in
renal cell carcinoma and regulates cell growth and apoptosis by
epigenetically silencing of LATS2. Biomed Pharmacother.
105:1133–1140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Song X, Wang X, Xie Y, Wang Z, Xu
Y, You X, Liang Z and Cao H: Circulating DNA of HOTAIR in serum is
a novel biomarker for breast cancer. Breast Cancer Res Treat.
152:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salomaa V, Havulinna A, Saarela O, Zeller
T, Jousilahti P, Jula A, Muenzel T, Aromaa A, Evans A, Kuulasmaa K
and Blankenberg S: Thirty-one novel biomarkers as predictors for
clinically incident diabetes. PLoS One. 5:e101002010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van de Vijver MJ, He YD, van't Veer LJ,
Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C,
Marton MJ, et al: A gene-expression signature as a predictor of
survival in breast cancer. N Engl J Med. 347:1999–2009. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paik S, Tang G, Shak S, Kim C, Baker J,
Kim W, Cronin M, Baehner FL, Watson D, Bryant J, et al: Gene
expression and benefit of chemotherapy in women with node-negative,
estrogen receptor-positive breast cancer. J Clin Oncol.
24:3726–3734. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang M, Klevebring D, Lindberg J, Czene K,
Grönberg H and Rantalainen M: Determining breast cancer
histological grade from RNA-sequencing data. Breast Cancer Res.
18:482016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heagerty PJ, Lumley T and Pepe MS:
Time-dependent ROC curves for censored survival data and a
diagnostic marker. Biometrics. 56:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harrell FE, Califf RM, Pryor DB, Lee KL
and Rosati RA: Evaluating the yield of medical tests. JAMA.
247:2543–2546. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Y, Yang Y, Dai J, Xing D and Dong Y:
IMPDH2 is highly expressed in breast cancer and predicts
unfavourable prognosis. Biomarkers. Jul 2–2018.(Epub ahead of
print). doi: 10.1080/1354750X.2018.1496360. View Article : Google Scholar
|
|
22
|
He K and Wang P: Unregulated long
non-coding RNA-AK058003 promotes the proliferation, invasion and
metastasis of breast cancer by regulating the expression levels of
the γ-synuclein gene. Exp Ther Med. 9:1727–1732. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo J, Liu C, Wang W, Liu Y, He H, Chen C,
Xiang R and Luo Y: Identification of serum miR-1915-3p and
miR-455-3p as biomarkers for breast cancer. PLoS One.
13:e02007162018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Banerji S, Ni J, Wang SX, Clasper S, Su J,
Tammi R, Jones M and Jackson DG: LYVE-1, a new homologue of the
CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J
Cell Biol. 144:789–801. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mattila MM, Ruohola JK, Karpanen T,
Jackson DG, Alitalo K and Härkönen PL: VEGF-C induced
lymphangiogenesis is associated with lymph node metastasis in
orthotopic MCF-7 tumors. Int J Cancer. 98:946–951. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Skobe M, Hawighorst T, Jackson DG, Prevo
R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K and Detmar
M: Induction of tumor lymphangiogenesis by VEGF-C promotes breast
cancer metastasis. Nat Med. 7:192–198. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bono P, Wasenius VM, Heikkilä P, Lundin J,
Jackson DG and Joensuu H: High LYVE-1-positive lymphatic vessel
numbers are associated with poor outcome in breast cancer. Clin
Cancer Res. 10:7144–7149. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mcgreal EP, Miller JL and Gordon S: Ligand
recognition by antigen-presenting cell C-type lectin receptors.
Curr Opin Immunol. 17:18–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
van Gisbergen KP, Aarnoudse CA, Meijer GA,
Geijtenbeek TB and Van Kooyk Y: Dendritic cells recognize
tumor-specific glycosylation of carcinoembryonic antigen on
colorectal cancer cells through dendritic cell-specific
intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res.
65:5935–5944. 2005. View Article : Google Scholar : PubMed/NCBI
|
